Wound Care - ASEAN

  • ASEAN
  • Revenue in the Wound Care market amounts to US$83.18m in 2024. The market is expected to grow annually by 0.73% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.12 are generated in 2024.

Key regions: Philippines, India, Europe, United States, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in ASEAN is experiencing steady growth due to increasing customer preferences for advanced wound care products, rising healthcare expenditure, and the growing aging population in the region. Customer preferences in the Wound Care market in ASEAN are shifting towards advanced wound care products.

Customers are increasingly seeking products that promote faster wound healing, reduce pain, and minimize scarring. This has led to a growing demand for advanced wound dressings, such as hydrogels, foam dressings, and alginate dressings, which offer superior wound healing properties compared to traditional dressings. Additionally, customers are also showing a preference for wound care products that are easy to use, cost-effective, and provide long-lasting protection.

The market is also being driven by the rising healthcare expenditure in ASEAN countries. Governments in the region are increasing their healthcare budgets to improve access to healthcare services and enhance the quality of medical care. This has resulted in improved healthcare infrastructure, increased availability of wound care products, and greater affordability for customers.

As a result, more customers are able to access and afford advanced wound care products, driving market growth. The growing aging population in ASEAN is another key factor contributing to the development of the Wound Care market. As the population ages, the incidence of chronic wounds, such as diabetic ulcers and pressure ulcers, is increasing.

This has created a significant demand for wound care products that can effectively manage and treat these chronic wounds. Advanced wound care products, with their superior healing properties, are particularly well-suited for the treatment of chronic wounds in the elderly population. In addition to these global trends, there are also local special circumstances that are driving the growth of the Wound Care market in specific ASEAN countries.

For example, in countries like Singapore and Malaysia, where medical tourism is a significant industry, the demand for advanced wound care products is high. International patients who come to these countries for medical treatment often require specialized wound care products during their recovery process, creating a lucrative market for such products. Underlying macroeconomic factors, such as favorable government policies, economic growth, and increasing healthcare awareness, are also contributing to the growth of the Wound Care market in ASEAN.

Governments in the region are implementing policies to promote healthcare development and improve access to healthcare services. Economic growth is driving higher disposable incomes, enabling customers to afford advanced wound care products. Additionally, increasing healthcare awareness among the population is leading to a greater demand for wound care products and services.

Overall, the Wound Care market in ASEAN is experiencing growth due to customer preferences for advanced wound care products, rising healthcare expenditure, the growing aging population, local special circumstances, and underlying macroeconomic factors. This trend is expected to continue as the region's healthcare infrastructure continues to improve and customer awareness about advanced wound care products increases.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)